Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination

The U.S. Food and Drug Administration has to date granted approval or emergency use authorization to three vaccines against severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019. In clinical trials and real-use observational studies, the Pfizer-BioNTech BNT162b2 messenger RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, Benjamin, Apostolidis, Sokratis A., Bhatt, Vatsal, Greenplate, Allison R., Kallish, Staci, LaCava, Anthony, Lucas, Alfredo, Meyer, Nuala J., Negoianu, Dan, Ogdie, Alexis R., Shashaty, Michael G. S., Takach, Patricia A., Zuroff, Leah, Wherry, E. John, Anesi, George L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575416/
https://www.ncbi.nlm.nih.gov/pubmed/34765984
http://dx.doi.org/10.1097/CCE.0000000000000578

Ejemplares similares

Ejemplares similares